Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple intracellular mRNA targets via miRNA cargo refers to a therapeutic modality rather than a single molecular entity. This approach utilizes microRNAs (miRNAs)—small, non-coding RNA molecules—to simultaneously regulate a broad network of messenger RNA (mRNA) transcripts within a cell (Bartel, D. P., Cell, 2004). Unlike traditional small molecules that target a single protein, a single miRNA can bind to the 3' untranslated regions (UTRs) of hundreds of different mRNAs, allowing for the coordinated modulation of entire biological pathways (Rupaimoole, R., & Slack, F. J., Nature Reviews Drug Discovery, 2017). This strategy is particularly valuable in treating complex diseases like cancer, where multiple oncogenic drivers must be suppressed to prevent therapeutic resistance (Kalluri, R., & LeBleu, V. S., Science, 2020). The miRNA cargo is typically encapsulated in delivery vehicles such as lipid nanoparticles (LNPs) or exosomes to protect the RNA from degradation and facilitate cellular uptake. Once inside the cytoplasm, the miRNA integrates into the RNA-induced silencing complex (RISC) to mediate post-transcriptional gene silencing through mRNA cleavage or translational repression (Adams, B. D., et al., Molecular Therapy, 2017).
miRNAs are delivered into the intracellular environment (often via exosomes or lipid nanoparticles) where they are loaded into the RNA-induced silencing complex (RISC). The miRNA then acts as a guide to bind complementary sequences, typically in the 3' untranslated regions (UTRs), of multiple target mRNAs, leading to their degradation or the inhibition of their translation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple intracellular mRNA targets via miRNA cargo.